Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare
Sonoma Pharmaceuticals Inc. Net Income 2011–2025
Sonoma Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2011 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Sonoma Pharmaceuticals Inc. net income for the quarter ending December 31, 2025 was -819000, a 11.75% decrease year-over-year.
- Sonoma Pharmaceuticals Inc. net income for the twelve months ending December 31, 2025 was -3.5 M, a 14.16% decrease year-over-year.
- Sonoma Pharmaceuticals Inc. annual net income for 2025 was -3.5 M, a 28.50% decrease from 2024.
- Sonoma Pharmaceuticals Inc. annual net income for 2024 was -4.8 M, a 6.13% decrease from 2023.
- Sonoma Pharmaceuticals Inc. annual net income for 2023 was -5.2 M, a 1.28% increase from 2022.
- Sonoma Pharmaceuticals Inc. annual net income for 2022 was -5.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sonoma Pharmaceuticals Inc. Net Income — FAQ
Sonoma Pharmaceuticals Inc. (SNOA) net income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Sonoma Pharmaceuticals Inc.'s net income?
Sonoma Pharmaceuticals Inc. (SNOA) reported net income of -$3M for fiscal 2025.
Where can I see SNOA's net income history?
The chart and table above show Sonoma Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.